Chemotype Ii

Chemotype II refers to cannabis plants characterized by cannabinoid and terpene profiles dominated by CBD rather than THC, with terpene expression typically featuring myrcene, caryophyllene, and pinene. This chemotype classification emerged from European hemp breeding programs in the early 2000s, where cultivators systematically selected for high-CBD, low-THC genetics to meet regulatory frameworks. Chemotype II plants often display minimal psychoactive potential while maintaining complex aromatic and phytochemical profiles. The designation reflects standardized cannabinoid ratio thresholds used across seed suppliers and breeding registries, particularly in regions with strict THC limits. Understanding chemotype classification is essential for breeders developing stable CBD-dominant lines and for preserving genetic diversity within regulated cannabis cultivation.

Breeders targeting Chemotype II work to stabilize CBD-dominant expression while maintaining consistent terpene profiles across generations. This requires careful phenotype selection and backcrossing to establish reliable seed lines that meet both cannabinoid ratios and legal compliance thresholds.